Actavis Luxembourg
Aktuelles Alle(s) Internal Produkt Commitment Anderes Year Alle(s) 2012 2011 2010 2009
• drittgrösstes globales Generika-Unternehmen entsteht • 2012 kombinierte Umsatzerlöse in Höhe von USD8 Milliarden auf Pro-Forma-Basis erwartet • deutliche Erweiterung von Watsons
Global managed-care offering to help bring down treatment costs for 366 million diabetics Actavis and Bioton (WSE:BIO) announced today that they have formed a joint venture company for the
Actavis Group, the international generic pharmaceuticals company, has acquired 100% of the shares in PharmaPack International B.V. for an undisclosed amount. PharmaPack is based in Zoetermeer,